Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Politics & Policy

China biopharma stocks fall after centralized tendering talks

September 12, 2018 11:41 PM UTC

Stocks of Chinese biopharma companies slid on Wednesday, possibly in response to a meeting Tuesday of China's National Medical Insurance Bureau on the centralized procurement of generics. Under centralized procurement, a single generic manufacturer would gain a 70% market share in 11 Chinese cities, according to a Chinese government news source.

Price cuts for generic versions of 33 listed drugs could range between 10-40% under the process, the source said. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article